Most importantly, our initial analysis suggests that the methylator phenotype, which is associated with the more aggressive subtype of tumour, the YST, is also associated with increased expression of DNMT3B. It will now be important to determine directly whether it is DNMT3B itself or another factor(s) that is the cause of the altered methylation. Here, DNMT3B is linked to neoplasm.